Search Results for “H19-423_V1.0 Latest Test Testking 🍀 H19-423_V1.0 Practical Information 📄 H19-423_V1.0 Test Price 🕔 Go to website ☀ www.pdfvce.com ️☀️ open and search for ➠ H19-423_V1.0 🠰 to download for free 🎤H19-423_V1.0 Download Pdf” – Page 40

Urticaria: Its History-Based Diagnosis and Etiologically Oriented Treatment

25.	Maurer, M. and Grabbe, J.: Urtikaria – gezielte Anamnese und ursachenorientierte Therapie. Dtsch. Ärztebl. 2008: 105; 458-466. IF: N/A (EN)

H1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients’ Perspective of Effectiveness and Side Effects – A Retrospective Survey Study

116

Weller, K., Ziege, C., Staubach, P., Brockow, K., Siebenhaar, F., Krause, K., Altrichter, S., Church, M. K., and Maurer, M.+: H1-Antihistamine up-dosing in chronic spontaneous urticaria: Patients’ perspective of effectiveness and side effects – a retrospective survey study. PLoS ONE 2011: 6; e23931. IF: 4.09

Inventory and taxonomy of phlebotomine sand flies of the Mokolo leishmaniasis focus, northern Cameroon, with description of new Sergentomyia taxa (Diptera: Psychodidae)

349

Ngouateu Tateng, A., Khan Payne, V., Ngouateu, O. B., Kirstein, O. D., Warburg, A., von Stebut-Borschitz, E., Maurer, M., Dondji, B.+, and Krüger, A.+: Inventory and taxonomy of phlebotomine sand flies of the Mokolo leishmaniasis focus, northern Cameroon, with description of new sergentomyia taxa (diptera: psychodidae). Acta Trop. 2019: 194; 172-180. IF: 2.55

o.349

281	Finlay, A. Y.+, Kaplan, A. P., Beck, L. A., Antonova, E. N., Balp, M. M., Zazzali, J., Khalil, S., and Maurer, M.:Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria. J. Eur. Acad. Dermatol. Venereol. 2017: 31; 1715-1721. IF: 4.29

32.	Metz, M. and Maurer, M.: Innate immunity and allergy in the skin. Curr. Opin. Immunol. 2009: 21; 687-693. IF: 10.88

Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2-induced airway inflammation and remodeling

276

Tabeling, C., Herbert, J., Hocke, A. C., Lamb, D., Wollin, L., Erb, K., Boiarina, E., Movassagh, H., Scheffel, J., Doehn, J. M., Hippenstiel, S., Maurer, M. Gounni, A., S., Kuebler, W. M., Suttorp, N., and Witzenrath, M.: Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2-induced airway inflammation and remodeling. Allergy 2017: 72; 1061-1072. IF: 6.05

127	Vukman, K. V., Visnovitz, T., Adams, P. N., Metz, M., Maurer, M. and O’Neill, S. M.+: Mast cells cultured from IL-3 treated mice show impaired responses to bacterial antigen stimulation. Inflamm. Res. 2012: 61; 79-85. IF: 1.96

132	Weller, K., Viehmann, K., Bräutigam, M., Krause, K., Siebenhaar, F., Zuberbier, T., and Maurer, M.+: Cost-intensive, time-consuming, problematical? – How physicians in private practice experience the care of urticaria patients. J. Dtsch. Dermatol. Ges. 2012: 10; 341-347. IF: 1.40

Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double‐blind, placebo‐controlled study

339

Metz, M., Torene, R., Kaiser, S., Beste, M. T., Staubach, P., Bauer, A., Brehler, R., Gericke, J., Letzkus, M., Hartmann, N., Erpenbeck, V. J.*, and Maurer, M.*+: Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: a randomized, double-blind, placebo-controlled study. Allergy 2019: 74; 141-151. IF: TBD (IF 2018: 6.77)

272	Garbani, M., Xia, W., Rhyner, C., Prati, M., Scheynius, A., Malissen, B., Engqvist, H., Maurer, M. Crameri, R., and Terhorst, D.: Allergen-loaded strontium-doped hydroxyapatite spheres improve allergen-specific immunotherapy in mice. Allergy 2017: 72; 570-578. IF: 6.05

Results